NEUROONE MEDICAL TECHNOLOGIES CORPORATION

Press Releases NeuroOne Medical Technologies Corporation

Equities

NMTC

US64130M2098

Market Closed - Nasdaq Other stock markets 16:30:01 2024-05-10 EDT			5-day change	1st Jan Change
1.12 ^USD	-3.45%		-4.27%	-29.11%

03-26	NeuroOne Medical Technologies Corporation Initiates Limited Commercial Launch of OneRF Ablation System	CI
02-13	Transcript : NeuroOne Medical Technologies Corporation, Q1 2024 Earnings Call, Feb 13, 2024

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

NeuroOne® to Report Second Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on May 14	05-10	AQ
NeuroOne® CEO Dave Rosa Featured on Bloomberg Technology	04-10	AQ
NeuroOne® Announces First Implant of OneRF™ Ablation Electrodes	04-09	AQ
NeuroOne® CEO Dave Rosa Featured on Fox Business Network’s Varney & Co.	04-04	AQ
NeuroOne® Initiates Limited Commercial Launch of OneRF™ Ablation System	03-26	AQ
NeuroOne to Participate in the 36th Annual Roth Conference	03-11	AQ
NeuroOne® to Participate in the 36th Annual Roth Conference	03-08	AQ
NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	02-23	AQ
NeuroOne® Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update	02-13	AQ
NeuroOne® to Report First Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on February 13	02-08	AQ
NeuroOne® Reports Fiscal Fourth Quarter and Full Fiscal Year 2023 Financial Results and Provides Corporate Update	12-14	AQ
NeuroOne® Receives FDA 510(k) Clearance to Market its OneRF™ Ablation System	12-11	AQ
NeuroOne® to Report Fourth Quarter and Fiscal Year 2023 Financial Results and Provide Corporate Update on December 14	12-07	AQ
Thinking about buying stock in Adial Pharmaceuticals, Ares Capital Corp, SilverSun Technologies, Neuroone Medical Technologies, or enGene Holdings?	12-05	PR
NeuroOne® Announces Patent Allowance for Drug Delivery Utilizing a Novel Neural Probe	11-16	AQ
NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	11-14	AQ
NeuroOne® Provides Progress Update on FDA 510(k) Submission for OneRF™ Ablation System	11-07	AQ
NeuroOne® to Present at the ThinkEquity Conference on October 19, 2023	23-10-13	AQ
NeuroOne® to Present at the H.C. Wainwright 25th Annual Global Investment Conference	23-09-06	AQ
NeuroOne® Reports Third Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update	23-08-14	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases NeuroOne Medical Technologies Corporation

Equities

NMTC

US64130M2098

Press Releases

Filters